Log in to save to my catalogue

Performance Evaluation of Montelukast Pediatric Formulations: Part I—Age-Related In Vitro Conditions

Performance Evaluation of Montelukast Pediatric Formulations: Part I—Age-Related In Vitro Conditions

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8817206

Performance Evaluation of Montelukast Pediatric Formulations: Part I—Age-Related In Vitro Conditions

About this item

Full title

Performance Evaluation of Montelukast Pediatric Formulations: Part I—Age-Related In Vitro Conditions

Publisher

Cham: Springer International Publishing

Journal title

The AAPS journal, 2022-01, Vol.24 (1), p.26-26, Article 26

Language

English

Formats

Publication information

Publisher

Cham: Springer International Publishing

More information

Scope and Contents

Contents

This study aimed to explore the potential of biopharmaceutics
in vitro
tools to predict drug product performance in the pediatric population. Biorelevant dissolution set-ups were used to predict how age and medicine administration practices affect the
in vitro
dissolution of oral formulations of a poorly water-soluble compound, monteluk...

Alternative Titles

Full title

Performance Evaluation of Montelukast Pediatric Formulations: Part I—Age-Related In Vitro Conditions

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8817206

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8817206

Other Identifiers

ISSN

1550-7416

E-ISSN

1550-7416

DOI

10.1208/s12248-021-00661-2

How to access this item